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DNA METHYLATION OF SPECIFIC CPG SITES IN THE MMP-13 PROMOTER
REDUCES ITS ACTIVITY IN HUMAN CHONDROCYTES: LUCIFERASE ASSAY
WITH CPG-FREE REPORTER VECTOR
K. Hashimoto1, M. Otero1, H.I. Roach2, M.B. Goldring1
1Hosp. for Special Surgery, New York, NY; 2Univ. of Southampton,
Southampton, United Kingdom
Purpose: In osteoarthritis (OA), articular chondrocytes undergo phenotypic
change and acquire the ability to over-express genes such as matrix
metalloproteinases (MMP)-3,9 and 13, ADAMTS-4 and interleukin-1 beta
(IL1B). Previous studies have shown that, among the epigenetic changes,
DNA methylation at CpG sites in the relevant promoters is correlated with
the aberrant expression of different genes. Indeed, long-term treatment
with inﬂammatory cytokines can cause aberrant and sustained gene ex-
pression along with loss of DNA methylation in vitro. More importantly,
de-methylation on the CpG sites within the proximal MMP13 promoter
was found to be relevant for its aberrant expression in OA chondro-
cytes. However, how CpG methylation status intervenes to determine
the promoter activity of genes such as MMP13 is still not known. The
aims of the study were to determine 1) whether differences in CpG
methylation status directly affect MMP13 promoter activity and 2) which
CpG sites are responsible for changes in MMP13 promoter responses in
chondrocytes.
Methods: A CpG-free luciferase reporter vector (pCpG-Luc) was generated
according to the literature (Klug et al., Epigenetics, 127-130; 2006). The
promoter region of MMP-13 was PCR-ampliﬁed to produce constructs
containing different sequences (-372/+14, -214/+14 and -86/+14) of the
proximal promoter with 7, 4 and 1 CpG(s), respectively. Each promoter
construct was inserted in the pCpG-Luc backbone and treated with DNA
methyltransferase (SssI) to methylate all CpG sites in the inserted promoter
sequences. Each SssI-treated or untreated vector was co-transfected with
a Renilla luciferase vector into the human chondrocytic cell line, C28/I2,
by lipofection. The transfected cells were lysed 24 hours after transfection
and transferred to a 96-well plate, and then Fireﬂy and Renilla substrates
were applied, followed by the light detection with LMax II 384 luminometer
(Molecular Devices, CA). The plain pCpG-Luc vector (backbone) and the
pCpG-Luc vector containing an active CpG-free promoter (pCpG-Luc-CMV)
were also tested in methylated/non-methylated status.
Results: The backbone and pCpG-Luc-CMV activities were not changed
before and after SssI treatment, which indicates that the SssI methyl-
transferase treatment did not alter either the basal activity of the backbone
or the CMV promoter activity. The reporter activities of the -372/+14 and
-214/+14 MMP13 promoter constructs were decreased after SssI treat-
ment, whereas the -86/+14 MMP13 promoter activity was not signiﬁcantly
affected by methylation.
Conclusions: The CpG-free-Luc, which does not contain any CpG site,
allows for evaluation of the role of CpG methylation in various promoters.
Our results indicate that the three CpG sites within the region spanning
-214 to -86 bp of the proximal MMP13 promoter could be responsible for
the promoter activity in chondrocytes. Indeed, our results are consistent
with our previous ﬁnding, showing that de-methylation of the CpG site at
-110 bp of the MMP13 promoter correlates with its increased and aberrant
expression in OA chondrocytes.
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GENETIC POLYMORPHISMS OF LEPTIN AND ADIPONECTIN GENES AND
SUSCEPTIBILITY TO HAND OSTEOARTHRITIS IN FINNISHWOMEN
S. Hämäläinen, S. Solovieva, T. Vehmas, P. Leino-Arjas, A. Hirvonen
Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is a common disease characterised by de-
generation of the cartilage of synovial joints. Available evidence suggests
that genetic factors and overweight have a major role in the etiology of
OA. Our aim was to study the role of the Leptin (LEP) and Adiponectin
(ADIPOQ) genes in the individual susceptibility to hand OA in Finnish
women. Two single nucleotide polymorphisms (SNPs) ("-2548" rs7799039
and "+19" rs2167170) in LEP and four SNPs ("+276" rs1501299, "+46"
rs2241766, "-10068" rs182052 and "-11391" rs17300539) in ADIPOQ gene
were studied. Since the enzymes encoded by these genes play a critical role
in the regulation of body weight and energy homeostasis, they may also
inﬂuence the development of OA.
Methods: Bilateral hand radiographs of 543 Finnish female dentists and
teachers aged 45-63 years and living in the Helsinki metropolitan region
were examined and classiﬁed for the presence of OA using a modiﬁed
Kellgren-Lawrence (K-L) system and reference images. Hand OA was de-
ﬁned as at least mild (K-L > 2) hand OA in at least 2 ﬁnger joints.
The genotypes were determined by PCR-based methods. Data regarding
other risk factors were collected by questionnaire. Association between the
genotypes/diplotypes and hand OA were studied by logistic regression with
SPSS statistical package Version 15.0.
Results: The prevalence of hand OA in at least 2 joints was 42.4%, (45.7% in
dentists and 54.3% in teachers). The genotype frequencies were in Hardy-
Weinberg equilibrium in all of the six studied polymorphic loci. There were
no statistically signiﬁcant differences in the frequency of the genotypes
and carriage rates between the occupational groups, except in the ADIPOQ
-10068 loci. The genotype frequencies did not differ signiﬁcantly between
women with or without hand OA. When taking age and BMI into account
and stratiﬁed by occupation the LEP +19 and -2548 GA-genotypes showed
a protective effect compared with the GG- and AA-genotypes (OR 0.47, 95%
CI 0.27-0.84, p=0.01; 0.46, 0.25-0.86, p=0.02) respectively in the dentists
whereas this effect was not seen in the teachers. On the other hand, the
ADIPOQ -10068 GG- genotype increased the risk of hand OA compared
to the AA-genotype (2.14, 1.04-4.41, p=0.04) in dentists. Again, this effect
was not seen in the teachers. The ADIPOQ rs1501299, rs2241766, and
rs17300539 polymorphisms did not show any statistically signiﬁcant re-
sults. The haplotype analyses are currently underway. According to power
calculations, this study had 80% power to detect ORs from 1.63 to 2.71
depending on the minor allele frequency (4-47%), based on a two-sided
alpha of 0.05.
Conclusions: Our results support the hypothesis that the LEP and ADIPOQ
gene polymorphisms may play a role in the etiology of hand OA. There also
may be an interaction between the Leptin-related individual susceptibility
and hand workload.
390
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Chapel Hill, NC; 4Sch. of Med., Univ. of Sheﬃeld, Sheﬃeld, United Kingdom;
5Dept. of Med., Univ. of North Carolina, Chapel Hill, NC
Purpose: There are currently no approved drugs for the treatment or
prevention of osteoarthritis (OA), due in part to the complexities of clinical
trials in which only a small subset of patients show progression of the
disease during the studies. Mechanisms underlying the development or
progression of OA are not well understood. Although OA is not a classic
inﬂammatory disease, inﬂammatory mediators that degrade cartilage have
been implicated in its pathogenesis. We previously reported (Attur et al.
2009) that interleukin-1 receptor antagonist gene (IL1RN) variations (SNPs)
were associated with knee OA severity. In the present study, Caucasian
participants (N=1,173; 38% men; mean age=60 years) in the Johnson County
OA Project with 4-11 year follow-up data were selected to evaluate gene
variations associated with radiographic knee OA progression or initiation.
Methods: Anterior-posterior standing knee radiographs were obtained
with footmat positioning at both time points and read by a single muscu-
loskeletal radiologist for Kellgren-Lawrence grade (K-L, 0-4). Progression or
initiation of knee OA was deﬁned by an increase in KL grade or decrease in
joint space width in at least one knee. For progression of OA, subjects who
already had OA (KL≥2 at either knee) at baseline were included in analysis.
For initiation of OA, subjects without OA (KL≤1 at both knees) at baseline
were analyzed. A broad SNP panel was tested, including multiple genes and
dense coverage of the IL-1 gene cluster. Logistic or linear regression with
adjustment for age, gender and BMI was used to determine association
between IL1RN gene polymorphisms and progression or initiation of knee
OA.
Results: Speciﬁc SNPs and haplotypes of the IL1RN gene were signiﬁ-
cantly associated with progression or initiation of knee OA. There are
2 linkage disequilibrium (LD) blocks in the IL1RN gene, and markers in
both blocks were signiﬁcantly associated with initiation and progression
of knee OA. Allele C of the IL1RN rs4251961, previously reported to be
